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Abstract 
Background: Flexible optical bronchoscopes are essential for management of airways in ICU, but the conventional 
reusable flexible scopes have three major drawbacks: high cost of repairs, need for decontamination, and possible 
transmission of infectious agents. The main objective of this study was to measure the cost of bronchoalveolar lavage 
(BAL) and percutaneous tracheostomy (PT) using reusable bronchoscopes and single‑use bronchoscopes in an ICU of 
an university hospital. The secondary objective was to compare the satisfaction of healthcare professionals with reus‑
able and single‑use bronchoscopes.
Methods: The study was performed between August 2009 and July 2014 in a 16‑bed ICU. All BAL and PT procedures 
were performed by experienced healthcare professionals. Cost analysis was performed considering ICU and hospital 
organization. Healthcare professional satisfaction with single‑use and reusable scopes was determined based on 
eight factors. Sensitivity analysis was performed by applying discount rates (0, 3, and 5%) and by simulation of six situ‑
ations based on different assumptions.
Results: At a discount rate of 3%, the costs per BAL for the two reusable scopes were 188.86€ (scope 1) and 185.94€ 
(scope 2), and the costs per PT for the reusable scope 1 and scope 2 and single‑use scopes were 1613.84€, 410.24€, 
and 204.49€, respectively. The cost per procedure for the reusable scopes depended on the number of procedures 
performed, maintenance costs, and decontamination costs. Healthcare professionals were more satisfied with the 
third‑generation single‑use Ambu® aScope™.
Conclusions: The cost per procedure for the single‑use scope was not superior to that for reusable scopes. The 
choice of single‑use or reusable bronchoscopes in an ICU should consider the frequency of procedures and the num‑
ber of bronchoscopes needed.
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Background
Flexible optical bronchoscopes are essential for man-
agement of airways when performing bronchoalveolar 
lavage (BAL), intubation, airway suctioning, and per-
cutaneous tracheostomy (PT) in intensive care units 
(ICUs) [1–3]. However, the conventional reusable flexible 
scopes have three major drawbacks: high cost of repairs, 
need for decontamination, and possible transmission of 
Creutzfeldt–Jakob disease or other infectious agents [4, 
5]. The single-use flexible Ambu® aScope™ (Ambu A/S, 
Ballerup, Denmark) is designed for tracheal intubation 
and has the advantages that repair and disinfection are 
not needed [6]. Nonetheless, research is needed to assess 
the efficacy of this new device and to determine that it 
meets the current standards for reusable flexible bron-
choscopes. Piepho et  al. [6] studied the aScope™ and 
reported lower success rate for intubation and limited 
Open Access
*Correspondence:  sperbet@chu‑clermontferrand.fr 
6 Réanimation Médico‑Chirugicale, Pôle de Médecine Péri‑Opératoire, 
Hôpital Gabriel‑Montpied, CHU Clermont‑Ferrand, 58 Rue Montalembert, 
63000 Clermont‑Ferrand Cedex, France
Full list of author information is available at the end of the article
Page 2 of 6Perbet et al. Ann. Intensive Care  (2017) 7:3 
capacity to perform airway suctioning. Two additional 
drawbacks of the aScope™ are availability of only one size 
and its low image resolution [7, 8]. Mankikian found a 
global satisfaction with another type of single-use devices 
in clinical practice and for BAL in ventilated piglets [9].
Three previous studies performed cost-effectiveness or 
cost-minimization analysis to compare reusable flexible 
scopes with single-use scopes. Gupta et al. [10] and Aïs-
sou et al. [11] concluded that single-use scopes should be 
considered as alternative devices and that their cost range 
was similar to reusable scopes. Tvede et al. [12] reported 
that single-use scopes were more expensive than reus-
able scopes in their institution, but this depended on the 
number of flexible optic intubations per year; the cost 
for disposable scopes was lower if there were only few 
intubations per year. However, these studies had several 
limitations, in that they did not consider all costs or cost 
discounting and they did not perform sensitivity analyses.
The research team of our university hospital reviewed 
these previous studies and hypothesized it would be bet-
ter to have both types of scopes available, rather than 
one or the other. They developed a protocol to test this 
hypothesis based on BAL and PT procedures that were 
performed in an ICU that considered the advantages and 
drawbacks of each scope.
The main objective of this study was to measure cost 
per BAL performed by reusable scopes and the cost per 
PT performed by reusable and single-use scopes in an 
ICU of a university hospital. The secondary objective was 
to measure healthcare professional satisfaction with the 
three generations of single-use scopes.
Methods
Setting
The study was performed in the ICU of a single institu-
tion (University Hospital of Clermont-Ferrand, Cler-
mont-Ferrand, France) that had 16 beds. Two reusable 
fiberscopes, an Olympus® LF-TP (Olympus Optical Co. 
Ltd, Tokyo, Japan) and a Pentax® FI-16BS (Pentax France, 
Argenteuil), were available for all kinds of airways man-
agement. They were listed as fiberscopes 1 and 2 (Fib1 
and Fib2). The single-use Ambu® aScope™ was available 
for PT only. The study was performed between August 
2009 and July 2014. All procedures (BAL and PT) were 
performed in the ICU by senior physicians.
Because this study was observational and did not 
change the daily practice, the Research Ethics Commit-
tee of the Hospital of Cannes approved the present study 
and waived informed consent was authorized (Research 
Ethics Committee of the Hospital of Cannes, ceth_s03). 
However, the patient’s next of kin was systematically 
orally informed and could refuse patient participation. 
Moreover, the patient was later and as soon as possible 
systematically informed and could refuse his data to be 
used.
Materials
The two reusable scopes required decontamination 
after each use. There were two decontamination proce-
dures, depending on the type of scope and the duration 
between uses, according to the national guidelines of the 
Health General Direction. Decontamination procedures 
were manual, because no mechanical washer disinfector 
was available in our hospital. If a scope was used in the 
previous 7  days, a two-part 60-min incomplete decon-
tamination procedure was performed: 20  min before 
use (including preparation, one soak, and cleaning) and 
40 min after use (cleaning, three soaks with cleaning, dry-
ing, and storage). In other cases, a complete procedure of 
75 min (35 min before use and 40 min after use) was per-
formed. In case of damage, the reusable scope was sent to 
the manufacturer and no other scope replaced it.
Three generations of single-use aScopes were used: The 
first one could be used for 30-min maximum, the second 
one for 8-h maximum (limitation by manufacturer), and 
the third one with no limitation. A short screening decon-
tamination of 5 min was performed as recommended.
Cost measurement
For the reusable flexible scopes, the cost of purchase, tax 
write-off (amortization), insurance policy, repairs, and 
decontamination procedures were included (Additional 
file 1: Table S1). The purchase cost included the specific 
cost for each fiberscope and the common costs. The spe-
cific cost for the fiberscope 2 included the cost paid for 
the device, battery, and cable; the specific cost for the fib-
erscope 1 included the cost paid for the device, light, and 
cable. The common costs included storage bags for the 
devices and the impermeability tester. Only the Olympus 
scope had an insurance policy, and this was established 
in 2014. The assumption was that one-tenth of the total 
cost of the reusable scope was written off. The repair 
costs were paid to the manufacturer. The decontamina-
tion cost included the time that nurses spent perform-
ing the cleaning and the cost of cleaning materials. There 
were no waste management costs because these were the 
manufacturer’s responsibility.
For the single-use scope, the cost of purchase, decon-
tamination, and waste management were included. The 
purchase cost was paid to the manufacturer. The decon-
tamination costs included the time that nurses spent 
performing the cleaning and the costs of associated 
materials. Single-use scopes have a risk of being infec-
tious after use and must be burned. The cost of burning 
one single-use scope was based on the known cost of 
burning 1 tonne of waste.
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Sensitivity analysis
A sensitivity analysis that considered all the assumptions 
made in the cost analysis was used to assess the robust-
ness of our results. First, results were discounted at three 
different rates (0, 3, and 5%) by considering that all costs 
occurred at the beginning of the year, as recommend 
by Drummond et al. [13]. Second, the variables, type of 
scope, repairs, insurance policy, and number of airway 
management procedures (BAL or PT) were assessed in 
seven different simulations (see below). The results of 
the simulations are expressed at a discount rate of 3%. 
The annual repair costs used in the simulations were cal-
culated from the total costs in the 5  years of the study: 
3424€ for the fiberscope 1 and 3149€ for the fiberscope 2.
The first simulation modeled the current situation in 
our ICU without considering the insurance policy for the 
fiberscope 1. The second simulation modeled the use of 
the reusable and disposable scopes with equal frequency, 
repairs for reusable scopes, and no insurance for the fiber-
scope 1. The third simulation was the same as the second 
simulation, except without repairs and with an insurance 
policy for the fiberscope 1. The fourth and fifth simula-
tions were the same as the second simulation, except 
for the more frequent use of the reusable scope 1 in the 
fourth simulation (2/3 vs. 1/3) and the more frequent use 
of the reusable scope 2 in the fifth simulation (2/3 vs. 1/3). 
The sixth simulation assessed the impact of an increase in 
repair costs with all other factors the same. These six sim-
ulations were performed for 100 airway management pro-
cedures per year, based on the yearly average activity of 
our ICU. The seventh simulation considered the evolution 
of cost per airway management for the reusable and dis-
posable scopes, assuming that one reusable fiberscope is 
needed for 50 procedures. A modelisation was performed 
based on the average activity per year.
Measurement of physician satisfaction
The satisfaction of healthcare professionals with the sin-
gle-use scopes relative to reusable scopes was measured 
by a numeric scale from 0 (less satisfied with single-use 
scope) to 100 (more satisfied with single-use scope). The 
satisfaction scores were measured separately for the three 
generations of single-use scopes. This scoring consid-
ered eight factors, including implementation, anatomic 
landmarks, device insertion, tracheal positioning, qual-
ity of picture, luminosity, kickstand and maneuverability, 
and global satisfaction. Drawbacks and advantages were 
noted for each specific scope.
Results
There were 518 airway management procedures per-
formed during the 5-year study period. A total of 457 
procedures were performed with reusable scopes (155 
with the fiberscope 1 [136 BAL and 19 PT] and 302 
with the fiberscope 2 [245 BAL and 57 PT]), and 61 PT 
procedures were performed with single-use scopes (15 
with first-generation scopes, 30 with second-generation 
scopes, and 16 with third-generation scopes).
Additional files 2 and 3: Tables S2 and S3 show the 
detailed costs for the reusable and single-use scopes. 
The major cost for the reusable scopes was the pur-
chase (Additional file  2: Table S2). The costs per BAL 
at a discount rate of 3% for the reusable scopes 1 and 2 
were 188.86€ and 185.94€, respectively (Additional file 3: 
Table S3). The costs per PT at a discount rate of 3% for 
the reusable scopes 1 and 2 and single-use scopes were 
1613.84€, 410.24€, and 204.49€, respectively (Additional 
file 3: Table S3). For the two reusable scopes, decontami-
nation and maintenance were the main expenditures 
when performing BAL, and maintenance and write-offs 
were the main expenditures when performing PT. These 
results remained robust when different discount rates 
were applied (Additional file 3: Table S3).
The simulations indicated that the cost per year 
ranged from 15,668.82€ to 30,821.67€, depending on 
the assumptions (Additional file 4: Table S4). Simulation 
one showed that the cost per procedure for the scope 1 
with an insurance policy was slightly lower than for the 
single-use scope. Simulations two, three, four, and five 
showed that as reusable scopes were used more often, the 
cost per procedure became close to or lower than that of 
the single-use scope. The cost per procedure remained 
robust when they were twice as the mean cost, for the 
scope 2 only (Simulation six in Additional file  4: Table 
S4). For reusable scopes, the cost per procedure dropped 
dramatically when the number of procedures increased 
except when the purchase of a second reusable device 
was needed (Fig. 1). The first break-even point was at 55 
procedures (BAL + PT) per year, considering equivalent 
usage of the different reusable fiberscopes.
Healthcare professionals had overall satisfaction with 
the single-use Ambu® aScope™ than compared with 
the reusable scopes (Table 1). Notably, the quality of the 
image, implementation, anatomic landmarks, device 
insertion, and tracheal positioning were correct, although 




Our analysis indicated that reusable scopes varied sig-
nificantly in cost depending on the number of procedures 
performed per year and that cost for purchase and main-
tenance were most significant. The cost per procedure for 
the reusable and single-use scopes were comparable when 
there were 55 procedures per year. Our sensitivity analysis 
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indicated that the cost for repairs can be reduced by an 
insurance policy, and this reduced expenses by about 900€ 
per year for the scope 1. A survey of healthcare profes-
sionals indicated greater satisfaction with the third-gener-
ation single-use scope than with the reusable scopes.
Comparisons with other studies
Two previous studies reported that the cost per BAL for 
reusable scopes and the cost per PT for the single-use 
scope were comparable to our results. More specifically, 
Tvede et  al. [12] measured a cost per intubation from 
177.7€ to 204.5€ for reusable scopes and 204.4€ for dis-
posable scopes. Aïssou et  al. [11] calculated a cost per 
intubation for reusable and single-use scopes of 206€ and 
200€, respectively. On the contrary, our costs were higher 
than reported by Gupta et  al. [10], who measured the 
2009 cost per intubation by a reusable scope as $119.75 
(82.63€ based on the exchange rate of January 2009). The 
break-even point in the present work cannot be com-












Number of airways 
managements 
Cost per airways management 
Fig. 1 Evolution of cost per airways management (EUR) when using one reusable scope per 50 airways managements per year comparing with 
single‑use scopes
Table 1 Results of healthcare professionals’ satisfaction when using the three generations of Ambu® aScope™ compared 
to reusable fiberscopes (value = 50)
IQR1 interquartile range 1, IQR3 interquartile range 3
aScopeTM1 aScopeTM2 aScopeTM3
Median IQR1 IQR3 Median IQR1 IQR3 Median IQR1 IQR3
Implementation 50 46.25 53.75 50 50 55 57.5 50 60
Anatomic landmarks 50 41.25 53.75 60 51.25 60 60 56.25 60
Device insertion 57.5 46.25 60 57.5 50 60 60 56.25 63.75
Tracheal positioning 55 50 60 60 51.25 60 60 51.25 60
Quality of picture 35 30 40 40 35 40 55 45 60
Luminosity 40 30 45 40 35 40 40 35 45
Kickstand and maneuverability 30 30 35 35 30 40 45 40 50
Global satisfaction 40 36.25 45 45 40 50 55 50 60
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settings. The same drop of decline of cost per airways 
management performed was observed for reusable scope 
also explaining by the higher capital expenditures repre-
sented by the purchase of these device.
A review of the literature indicated that previous studies 
examined the association between repair costs and num-
ber of procedures performed by experienced practitioners 
[14, 15]. The impact of an educational program on repair 
costs was also measured. Performance of such a program 
may help to reduce repair expenses for the reusable scopes.
Implications
The cost per procedure for single-use scopes remained 
stable in our sensitivity analysis. The satisfaction of 
healthcare professionals was greater for the third-gener-
ation disposable scope. Two different sizes of disposable 
scopes are now available. The ICU in a teaching hospital 
has a mission to educate inexperienced practitioners, so 
single-use scopes may be a more suitable instrument for 
airway management.
Strengths and limitations
The main strengths of our study are that we considered 
direct medical costs and that we performed sensitivity 
analysis to assess the robustness of the results. The main 
limitation is that we did not assess the effectiveness of the 
single-use scopes and that the choice of fibrescopes was 
appreciated by operators. A review of the literature indi-
cates that further research is needed to assess the effective-
ness of disposable scopes in daily practice [6–9, 16]. It is 
also important to measure bronchoscope failure rates and 
the medical consequences of failure on effectiveness and 
direct medical costs. We considered the limitation noted 
by Tvede et al. [12] in their measurement of the break-even 
point regarding the actual need for the device. However, 
we did not consider opportunity costs associated with 
decontamination by auxiliary nurses and automatic annual 
microbiological samples. Indeed, time spent for decon-
tamination procedures can be reassigned to patient care. 
The costs were considered with manual decontamination 
procedures, but they could be determined equally in case 
of mechanical centralized decontamination procedures. 
Another limitation was that BAL was not performed with 
single-use fiberscope, because the two first generation 
have not operator channel and then use of them was not 
validated by the pharmacy for BAL.
Conclusions
The cost per procedure for the single-use scope is com-
parable to that for reusable scopes. When an ICU is con-
sidering the use of reusable scopes or single-use scopes, 
it should consider the annual number of procedures and 
the number of scopes that are needed.
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